Bioimpedancia avanzada en la evaluación de la supervivencia y mejora del pronóstico clínico en el paciente oncológico

(1) Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, et al. Global Cancer Observatory: Cancer Today. Centro Internacional de Investigaciones sobre el Cáncer; 2020.

(2) Valenzuela-Landaeta K, Rojas P, Basfi-fer K. Evaluación nutricional del paciente con cáncer. Nutr Hosp. 2012; 27(2): 516-23.

(3) Marian M, August DA: Prevalence of malnutrition and current use of nutrition support in cancer patient study. JPEN J Parenter Enteral Nutr. 2014; 38(2): 163-5.

(4) Pereira MME, Queiroz MDSC, de Albuquerque NMC, Rodrigues J, Wiegert EVM, Calixto-Lima L, de Oliveira LC. The Prognostic Role of Phase Angle in Advanced Cancer Patients: A Systematic Review. Nutr Clin Pract. 2018; 33(6): 813-24.

(5) Gupta D, Lammersfeld CA, Vashi PG, King J, Dahlk SL, Grutsch JF, Lis CG. Bioelectrical impedance phase angle as a prognostic indicator in breast cancer. BMC Cancer. 2008; 8: 249.

(6) Maubec E, Oberlin O, Belhadj K, Roujeau JC. Subcutaneous inflammatory edema induced by MINE chemotherapy. Ann Dermatol Venereol. 2001; 128(4): 534-7.

(7) Amano K, Liu D, Bruera E, Hui D. Collapse of Fluid Balance and Association with Survival in Patients with Advanced Cancer Admitted to a Palliative Care Unit: Preliminary Findings. J Palliat Med. 2020; 23(4): 459-65.

(8) Park SE, Hwang IG, Choi CH, Kang H, Kim BG; et al. Sarcopenia is poor prognostic factor in older patients with locally advanced rectal cancer who received preoperative or postoperative chemoradiotherapy. Medicine (Baltimore). 2018; 97(48): e13363.

(9) Cardoso-Peña E, Soto Pina AE, Villanueva ÁG, López Chavez GE, Ramírez Martínez P, Ramírez Montoya H, et al. Visceral Adiposity Index in Breast Cancer Survivors: A Case-Control Study. Int J Endocrinol. 2020; 2020: 8874916.